Gene · 10892
Papers2,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combined detection of lymphocyte clonality and MALT1 translocations in bronchoalveolar lavage fluid for diagnosing pulmonary lymphomas. | Sci Rep | 2021 | 34873224 | PubTator, text mining | PubMed |
| Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology. | Front Oncol | 2021 | 34868996 | PubTator, text mining | PubMed |
| Clinical and Immunological Features of Human BCL10 Deficiency. | Front Immunol | 2021 | 34868072 | PubTator, text mining | PubMed |
| Monogenic Adult-Onset Inborn Errors of Immunity. | Front Immunol | 2021 | 34867986 | PubTator, text mining | PubMed |
| Immune Dysregulation in Patients With Chromosome 18q Deletions-Searching for Putative Loci for Autoimmunity and Immunodeficiency. | Front Immunol | 2021 | 34867966 | PubTator, text mining | PubMed |
| The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy. | Vaccines (Basel) | 2021 | 34835294 | PubTator, text mining | PubMed |
| Meningitis Caused by the Live Varicella Vaccine Virus: Metagenomic Next Generation Sequencing, Immunology Exome Sequencing and Cytokine Multiplex Profiling. | Viruses | 2021 | 34835092 | PubTator, text mining | PubMed |
| Patient-Specific Modeling of Diffuse Large B-Cell Lymphoma. | Biomedicines | 2021 | 34829885 | PubTator, text mining | PubMed |
| Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation. | Sci Immunol | 2021 | 34826258 | PubTator, text mining | PubMed |
| Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review. | Front Oncol | 2021 | 34820328 | PubTator, text mining | PubMed |
| Analysis of core genes for colorectal cancer prognosis based on immune and stromal scores. | PeerJ | 2021 | 34820188 | PubTator, text mining | PubMed |
| Bladder mucosa-associated lymphoid tissue lymphoma progressed from chronic cystitis along with a comparative genetic analysis during long-term follow-up: a case report. | Transl Androl Urol | 2021 | 34804832 | PubTator, text mining | PubMed |
| Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway. | Bioengineered | 2021 | 34802389 | PubTator, text mining | PubMed |
| Biphasic (5-2%) oxygen concentration strategy significantly improves the usable blastocyst and cumulative live birth rates in in vitro fertilization. | Sci Rep | 2021 | 34789773 | PubTator, text mining | PubMed |
| Linear Ubiquitination Mediates EGFR-Induced NF-κB Pathway and Tumor Development. | Int J Mol Sci | 2021 | 34769306 | PubTator, text mining | PubMed |
| DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment? | Int J Mol Sci | 2021 | 34769081 | PubTator, text mining | PubMed |
| Impact of the J Project on progress of primary immunodeficiency care in Ukraine. | Cent Eur J Immunol | 2021 | 34764795 | PubTator, text mining | PubMed |
| Enriched transcriptome analysis of laser capture microdissected populations of single cells to investigate intracellular heterogeneity in immunostained FFPE sections. | Comput Struct Biotechnol J | 2021 | 34745451 | PubTator, text mining | PubMed |
| Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL. | Cancer Cell | 2021 | 34739844 | PubTator, text mining | PubMed |
| Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment. | Exp Hematol Oncol | 2021 | 34732266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10892/papers?page=37